CD8A and cancer: GEM has the potential to augment the antitumor effects of cancer immunotherapy by suppressing Treg induction[25,38], and also reduces MDSC[39], but does not reduce CD4+ T cells, CD8+ T cells, NK cells, macrophages, or B cells[40].